These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 17903325)

  • 1. Obesity and cardiovascular disease.
    Pérez Pérez A; Ybarra Muñoz J; Blay Cortés V; de Pablos Velasco P
    Public Health Nutr; 2007 Oct; 10(10A):1156-63. PubMed ID: 17903325
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Obesity and cardiovascular disease: pathogenic mechanisms and potential benefits of weight reduction.
    Douketis JD; Sharma AM
    Semin Vasc Med; 2005 Feb; 5(1):25-33. PubMed ID: 15968577
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Pharmacological therapy of obesity].
    Pagotto U; Vanuzzo D; Vicennati V; Pasquali R
    G Ital Cardiol (Rome); 2008 Apr; 9(4 Suppl 1):83S-93S. PubMed ID: 18773755
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intra-abdominal obesity: an untreated risk factor for Type 2 diabetes and cardiovascular disease.
    Després JP
    J Endocrinol Invest; 2006; 29(3 Suppl):77-82. PubMed ID: 16751711
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of cardiovascular disease and risk factors in a type 2 diabetic population of the North Catalonia diabetes study.
    Jurado J; Ybarra J; Solanas P; Caula J; Gich I; Pou JM; Romeo JH
    J Am Acad Nurse Pract; 2009 Mar; 21(3):140-8. PubMed ID: 19302689
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in body weight and pulse: outcome events in overweight and obese subjects with cardiovascular disease in the SCOUT trial.
    Seimon RV; Espinoza D; Finer N; James WP; Legler UF; Coutinho W; Sharma AM; Van Gaal L; Maggioni AP; Sweeting A; Torp-Pedersen C; Gebski V; Caterson ID
    Int J Obes (Lond); 2015 May; 39(5):849-57. PubMed ID: 25520249
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effectiveness and cost-effectiveness of interventions that cause weight loss and reduce the risk of cardiovascular disease.
    Zomer E; Leach R; Trimmer C; Lobstein T; Morris S; James WP; Finer N
    Diabetes Obes Metab; 2017 Jan; 19(1):118-124. PubMed ID: 27649286
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is weight loss beneficial for reduction of morbidity and mortality? What is the controversy about?
    Nilsson PM
    Diabetes Care; 2008 Feb; 31 Suppl 2():S278-83. PubMed ID: 18227497
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiometabolic risk assessment: an approach to the prevention of cardiovascular disease and diabetes mellitus.
    Vasudevan AR; Ballantyne CM
    Clin Cornerstone; 2005; 7(2-3):7-16. PubMed ID: 16473256
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overweight and obesity and weight change in middle aged men: impact on cardiovascular disease and diabetes.
    Wannamethee SG; Shaper AG; Walker M
    J Epidemiol Community Health; 2005 Feb; 59(2):134-9. PubMed ID: 15650145
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Type 2 diabetes: fueling the surge of cardiovascular disease in women.
    Jones EJ; Appel SJ
    Nurs Womens Health; 2008 Dec; 12(6):500-13; quiz 514. PubMed ID: 19121055
    [No Abstract]   [Full Text] [Related]  

  • 12. The Look AHEAD Trial: Implications for Lifestyle Intervention in Type 2 Diabetes Mellitus.
    Dutton GR; Lewis CE
    Prog Cardiovasc Dis; 2015; 58(1):69-75. PubMed ID: 25936906
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Maintained intentional weight loss reduces cardiovascular outcomes: results from the Sibutramine Cardiovascular OUTcomes (SCOUT) trial.
    Caterson ID; Finer N; Coutinho W; Van Gaal LF; Maggioni AP; Torp-Pedersen C; Sharma AM; Legler UF; Shepherd GM; Rode RA; Perdok RJ; Renz CL; James WP;
    Diabetes Obes Metab; 2012 Jun; 14(6):523-30. PubMed ID: 22192338
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Established cardiovascular disease and CVD risk factors in a primary care population of middle-aged Irish men and women.
    Creagh D; Neilson S; Collins A; Colwell N; Hinchion R; Drew C; O'Halloran D; Perry IJ
    Ir Med J; 2002; 95(10):298-301. PubMed ID: 12542011
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Type 2 diabetes mellitus: a high-risk condition for cardiovascular disease irrespective of the different degrees of obesity.
    Song SH; Hardisty CA
    QJM; 2008 Nov; 101(11):875-9. PubMed ID: 18776208
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epidemiology of type 2 diabetes and cardiovascular disease: translation from population to prevention: the Kelly West award lecture 2009.
    Meigs JB
    Diabetes Care; 2010 Aug; 33(8):1865-71. PubMed ID: 20668155
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Very severely obese patients have a high prevalence of type 2 diabetes mellitus and cardiovascular disease.
    Vinciguerra F; Baratta R; Farina MG; Tita P; Padova G; Vigneri R; Frittitta L
    Acta Diabetol; 2013 Jun; 50(3):443-9. PubMed ID: 23447004
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevention Conference VII: Obesity, a worldwide epidemic related to heart disease and stroke: Group III: worldwide comorbidities of obesity.
    Caterson ID; Hubbard V; Bray GA; Grunstein R; Hansen BC; Hong Y; Labarthe D; Seidell JC; Smith SC;
    Circulation; 2004 Nov; 110(18):e476-83. PubMed ID: 15520332
    [No Abstract]   [Full Text] [Related]  

  • 19. Beyond glycemic control: treating the entire type 2 diabetes disorder.
    Brunton S
    Postgrad Med; 2009 Sep; 121(5):68-81. PubMed ID: 19820276
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.